KASOBEA

pharmaceutical preparations and human therapeutic preparations and agents for treating and preventing lipid diseases and conditions, cardiometabolic diseases and conditions, and pancreatitis; pharmaceutical preparations and human therapeutic preparations and agents for lowering protein apoc3 and triglyceride levels in blood, controlling blood glucose, and reducing abdominal pain and pancreatic inflammation; antisense oligonucleotides; injectable pharmaceuticals for metabolic diseases and conditions